Clinical trial
Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
NCT01046279 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hypertension Monitoring in Glioma Patients Treated With Bevacizumab
- Lead sponsor
- University of Zurich
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 31, 2010
- Completion date
- August 31, 2012
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioma patients